Clinical Trial Update: Study of Orally Administered MOMA-341 in Participants With Advanced or Metastatic Solid Tumors [Phase 1]

View source ↗

Summary

Phase 1 study evaluating oral MOMA-341 in adults with advanced or metastatic solid tumors, including endometrial, colorectal, and gastric cancers, with recruitm…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colorectal Cancer
• Deficient Mismatch Repair Cancer
• Endometrial Cancer
• Gastric Cancer
• Microsatellite Instability-high Cancer

Drugs mentioned

• MOMA-341 (MOMA-341)

Snippet

Sponsor: MOMA Therapeutics | Conditions: Advanced Solid Tumor, Metastatic Solid Tumor | Phase 1 | Status: RECRUITING